Stay updated on FLX475 Dose Escalation Trial in Combination With Pembrolizumab

Sign up to get notified when there's something new on the FLX475 Dose Escalation Trial in Combination With Pembrolizumab page.
Latest website image capture
Clouds background image

Latest updates to the FLX475 Dose Escalation Trial in Combination With Pembrolizumab page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.5%
    Check dated 2025-05-01T06:22:34.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-04-24T01:13:24.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new identifiers for the clinical trial FLX475-02 and the involvement of collaborators, specifically Merck Sharp & Dohme LLC. Additionally, the revision number has been updated to v2.15.0.
    Difference
    18%
    Check dated 2025-04-16T20:35:58.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 24, 2025.
    Difference
    0.8%
    Check dated 2025-04-09T14:17:34.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has replaced information on Nasopharyngeal Carcinoma with details about Transitional Cell Carcinoma.
    Difference
    0.4%
    Check dated 2025-04-02T00:17:07.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-03-18T14:40:48.000Z thumbnail image

Stay in the know with updates to FLX475 Dose Escalation Trial in Combination With Pembrolizumab

Enter your email address, and we'll notify you when there's something new on the FLX475 Dose Escalation Trial in Combination With Pembrolizumab page.